脑脊液MTBR-tau243是阿尔茨海默病tau缠结病理的特异性生物标志物
本文报道脑脊液微管结合区含243位残基的tau(MTBR-tau243)是特异性反映不溶性tau聚集的生物标志物,并在两个独立队列(BioFINDER-2,n=448;Knight阿尔茨海默病研究中心,n=219)中与多种磷酸化tau指标比较。MTBR-tau243与tau-PET和认知关联最强,与淀粉样蛋白-PET关联最低;与p-tau205联合可解释tau-PET负荷大部分方差(0.58≤R2≤0.75)。作者提出修订A/T/(N)标准,将MTBR-tau243纳入代表不溶性tau聚集的「T」。
要点
- MTBR-tau243是与tau-PET和认知关联最强的脑脊液指标,与淀粉样蛋白-PET关联最低。
- MTBR-tau243联合p-tau205可解释tau-PET负荷大部分方差(0.58≤R2≤0.75)。
- MTBR-tau243水平随不溶性tau聚集纵向升高,而脑脊液p-tau种类无此表现。
核心结论
- 脑脊液MTBR-tau243是不溶性tau聚集病理的特异性生物标志物,可用于干预性试验和患者诊断。
- 作者基于这些发现提出修订A/T/(N)标准,将MTBR-tau243纳入代表不溶性tau聚集的「T」。
研究设计与样本
- 在两个独立队列(BioFINDER-2,n=448;Knight阿尔茨海默病研究中心,n=219)中比较脑脊液MTBR-tau243与p-tau181、p-tau205、p-tau217和p-tau231。
主要发现
- MTBR-tau243与tau-PET和认知关联最强,与淀粉样蛋白-PET关联最低。
- MTBR-tau243联合p-tau205解释tau-PET负荷总方差(0.58≤R2≤0.75),预测认知指标的效能(0.34≤R2≤0.48)接近tau-PET(0.44≤R2≤0.52)。
- MTBR-tau243水平随不溶性tau聚集纵向升高,而脑脊液p-tau种类无此表现。
关键数值与推荐
- MTBR-tau243联合p-tau205解释tau-PET负荷方差为0.58≤R2≤0.75。
- 联合模型预测认知指标的效能为0.34≤R2≤0.48,tau-PET为0.44≤R2≤0.52。
临床怎么用
- 作者认为脑脊液MTBR-tau243可用于干预性试验和患者诊断。
- 作者提出修订A/T/(N)标准,将MTBR-tau243纳入代表不溶性tau聚集的「T」。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aggregated insoluble tau is one of two defining features of Alzheimer's disease. Because clinical symptoms are strongly correlated with tau aggregates, drug development and clinical diagnosis need cost-effective and accessible specific fluid biomarkers of tau aggregates; however, recent studies suggest that the fluid biomarkers currently available cannot specifically track tau aggregates. We show that the microtubule-binding region (MTBR) of tau containing the residue 243 (MTBR-tau243) is a new cerebrospinal fluid (CSF) biomarker specific for insoluble tau aggregates and compared it to multiple other phosphorylated tau measures (p-tau181, p-tau205, p-tau217 and p-tau231) in two independent cohorts (BioFINDER-2, n = 448; and Knight Alzheimer Disease Research Center, n = 219). MTBR-tau243 was most strongly associated with tau-positron emission tomography (PET) and cognition, whereas showing the lowest association with amyloid-PET. In combination with p-tau205, MTBR-tau243 explained most of the total variance in tau-PET burden (0.58 ≤ R2 ≤ 0.75) and the performance in predicting cognitive measures (0.34 ≤ R2 ≤ 0.48) approached that of tau-PET (0.44 ≤ R2 ≤ 0.52). MTBR-tau243 levels longitudinally increased with insoluble tau aggregates, unlike CSF p-tau species. CSF MTBR-tau243 is a specific biomarker of tau aggregate pathology, which may be utilized in interventional trials and in the diagnosis of patients. Based on these findings, we propose to revise the A/T/(N) criteria to include MTBR-tau243 as representing insoluble tau aggregates ('T').
引用
- Horie K, Salvadó G, Barthélemy NR, et al. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease. Nat Med. 2023. PMID: 37443334. doi:10.1038/s41591-023-02443-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。